Filter by Date
Showing 14 results for "LabourMarket"
Order by:
Corporate News 12 Jan 2022 | 12:55 PM

HS Bio’s NeoGenix Laboratoire teams up with UM’s TIDREC

KUALA LUMPUR: Hong Seng Consolidated Bhd’s healthcare arm, HS Bio Sdn Bhd, has entered into a collaborative research and development (R&D) agreement with Universiti Malaysia’s Tropical Infectious Diseases Research and Education Centre (TIDREC).

Singapore 15 Sept 2024 | 05:24 AM

Wanted: 60,000 engineers, as Malaysia seeks talent to drive its chip-sector ambitions

Fifteen years ago, Terengganu-born Dr Salleh Ahmad could not find a job in Malaysia that matched his qualifications. He had just graduated from France’s top engineering school ESIEE Paris with an engineering degree in microelectronics in 2009 and wanted to design microchips for the aerospace sector.

Aseanplus News 26 July 2023 | 03:07 AM

Kalasin’s Phu Noi site reveals bones of Thailand’s 13th dinosaur

BANGKOK (The Nation/Asia News Network): Thai and French researchers have discovered an almost complete set of bones of a new breed of dinosaur at the Phu Noi archaeological site in the northeastern province of Kalasin.

Corporate News 26 Jan 2022 | 09:49 AM

Hong Seng's healthcare arm HS Bio acquires two industrial properties

KUALA LUMPUR: Hong Seng Consolidated Bhd has proposed to acquire a 100% stake in Premiumway Development Sdn Bhd (PDSB) for RM1.09mil.

SEARCH Scholar Series 2 May 2022 | 04:00 AM

Promoting a female labour force in Malaysia and China

THE COVID-19 pandemic has caused much economic and social hardship, including an increase in domestic violence compounded by limited mobility and social isolation.

Corporate News 8 Oct 2021 | 06:09 AM

Hong Seng to buy 51% stake in Pow Pocket for RM200mil

KUALA LUMPUR: Hong Seng Consolidated Bhd’s unit HS Bio Sdn Bhd is buying a 51% stake in Pow Pocket Sdn Bhd for RM200mil cash consideration which plans to roll out a nationwide end-to-end private Covid-19 vaccine programme.

Corporate News 2 Oct 2021 | 03:13 AM

Hong Seng to acquire 51% stake in RZAC Immunesafe for RM20mil

KUALA LUMPUR: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd (HS Bio) has entered into a share sale agreement to acquire a 51 per cent stake in the COVID-19 antibody test kit distributor RZAC Immunesafe Sdn Bhd for RM20 million.

Corporate News 6 Jan 2021 | 11:00 PM

Combination of funding proposed

PETALING JAYA: Hong Seng Consolidated Bhd will be funding its 60% acquisition of Neogenix Laboratoire Sdn Bhd for RM6.5mil via a combination of internally generated funds and proceeds received from the conversion of irredeemable convertible preference shares (Iculs).

Cambodia 29 Mar 2021 | 05:08 AM

Cambodia okays 5 projects worth US$1.3 billion, "mostly owned" by Chinese companies

PHNOM PENH, March 28 (Phnom Penh Post/ANN) - The Cambodian government on March 26 approved applications for five new investment projects worth about US$1.3 billion, to provide 2,250 workers jobs

Corporate News 7 Feb 2021 | 11:00 PM

Hong Seng banks on gloves and healthcare

PETALING JAYA: Hong Seng Consolidated Bhd which has been on a buying spree since the emergence of a new shareholder has its sights set on the glove and healthcare industries to carry the company forward.

Corporate News 3 Feb 2021 | 11:48 AM

Hong Seng unit wins RM34.25mil contract to supply Covid-19 test kits

KUALA LUMPUR: Hong Seng Consolidated Bhd said a 51% owned subsidiary, Pantasniaga Sdn Bhd, has secured a RM34.25mil contract to supply Covid-19 test kits the Institute of Medical Research.

Analyst Reports 4 Jan 2021 | 12:50 AM

Trading ideas: Mudajaya, Hong Seng, Top Builders, construction stocks

KUALA LUMPUR: Mudajaya, Hong Seng, Top Builders and construction stocks are among the counters which could see trading interest on Monday after their corporate announcements last Thursday, JF Apex Research says.

Corporate News 7 June 2021 | 11:00 PM

Hong Seng’s glove business to start ops

Hong Seng Consolidated Bhd says its first two glove production lines out of the eight planned for this year, should be up and running by the end of this month.

World 17 Apr 2020 | 04:00 PM

French nursing home learns costly lessons on containing coronavirus

PARIS (Reuters) - When managers at La Riviera nursing home on France's Cote D'Azur found out a resident had the COVID-19 virus, they put into action a standard playbook they believed would contain the spread. It did not.

Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In